Etanercept: A Breakthrough In Treating Spondyloarthritis

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on the use of Etanercept as an advanced therapy in managing spondyloarthritis. We have Dr S Ramesh as the moderator, and Dr S Sham and Dr M Hema as the speakers in this session.

Spondyloarthritis is a type of arthritis where the spine is affected and, in some cases, the joints of the arms and legs are also affected. It can also involve the skin, intestines and eyes. The primary symptom observed in most patients is low back pain, mostly axial spondyloarthritis. 

It is thought that spondyloarthritis develops through the interaction of genetic and environmental factors. Further, spondyloarthropathies (SpA) is recognised as autoimmune disease as it is strongly associated with HLA-B27, a gene variant that controls immune responses. 

Etanercept, a TNF inhibiting drug, can be an advanced treatment option in managing spondyloarthritis. These are mostly used for people with rheumatoid arthritis or other rheumatic disease.

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars